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ABSTRACT 
The dynamic link between the nanoscale spatial distribution of biomolecules and their 
functional impact on cellular and downstream biological behaviors has been hypothesized, 
but only supported by limited evidences. This is mostly due to the lack to methods to 
fabricate well-defined patterns of biomolecules. In this thesis, we utilized the DNA origami 
method to create protein ligand and antigen patterns with high precision, and applied it to 
study cell signaling events in a cancer cell line and complex antibody-antigen interactions. In 
addition, to achieve quality fabrication of our protein and antigen functionalized DNA 
origami nanostructures we developed and adapted several DNA and protein purification 
methods. Finally, we employed the versatility of the DNA origami method to create anti-
cancer drug carriers with tunable drug release kinetics.  
  
 LIST OF SCIENTIFIC PAPERS 
I. Shaw, A.; Lundin, V.; Petrova, E.; Fördős, F.; Benson, E.; Al-Amin, A.; 
Herland, A.; Blokzijl, A.; Högberg, B.; Teixeira, A. I. Spatial Control of 
Membrane Receptor Function Using Ligand Nanocalipers. Nat. Methods 
2014, 11, 841–846. 
II. Shaw, A.; Högberg, B. Resolving Peculiar Antibody-Antigen Interactions 
with Patterned Surface Plasmon Resonance. Manuscript. 
III. Shaw, A.; Benson, E.; Högberg, B. Purification of Functionalized DNA 
Origami Nanostructures. ACS Nano 2015, 9, 4968–4975. 
IV. Zhao, Y.-X.; Shaw, A.; Zeng, X.; Benson, E.; Nyström, A. M.; Högberg, B. 
DNA Origami Delivery System for Cancer Therapy with Tunable Release 
Properties. ACS Nano 2012, 6, 8684–8691. 
  
CONTENTS 
1 Introduction ..................................................................................................................... 1 
1.1 The DNA origami method .................................................................................... 1 
1.2 Bioorthogonal click chemistry and bioconjugation .............................................. 2 
1.3 Ephrin and Eph ...................................................................................................... 5 
1.4 The flexibility and binding patterns of antibodies ................................................ 6 
1.5 Production and purification of functionalized DNA origami .............................. 8 
1.6 DNA origami as drug delivery vessels ................................................................. 9 
2 Materials and Methods .................................................................................................. 10 
2.1 Design and fabrication of DNA origami nanostructures .................................... 10 
2.1.1 caDNAno ................................................................................................. 10 
2.1.2 Fabrication the DNA origami nanostructures ........................................ 10 
2.1.3 Bioconjugation between proteins and oligonucleotide handles ............. 11 
2.1.4 Functionalization of DNA origami nanostructures ................................ 13 
2.1.5 Purification of the functionalized DNA origami nanostructures ........... 13 
2.2 Studying binding kinetics with surface plasmon resonance .............................. 14 
2.2.1 Ephrin-A5-Fc and EphA2 binding kinetics ............................................ 14 
2.2.2 Antibody binding kinetics ....................................................................... 14 
2.3 Cellular signaling experiments ............................................................................ 15 
2.3.1 Cell culture and Eph receptor stimulation .............................................. 15 
2.3.2 Cell invasion assay .................................................................................. 16 
3 Results and Discussion .................................................................................................. 17 
3.1.1 Folding and functionalization of DNA origami nanostructures 
(Paper I) ................................................................................................... 17 
3.1.2 Characterization of the bio-availability of ephrin-A5-Fc 
nanocalipers (Paper I) ............................................................................. 19 
3.1.3 Spatial regulation of EphA2 receptor activation (Paper I) ..................... 21 
3.1.4 Studying antibody flexibility and complex antigen binding with 
PSPR (Paper II) ....................................................................................... 23 
3.1.5 Purification of functionalized DNA origami nanostructures (Paper 
III) ............................................................................................................ 25 
3.1.6 DNA origami drug delivery system with tunable release properties 
(Paper IV) ................................................................................................ 29 
4 Acknowledgements ....................................................................................................... 33 
5 References ..................................................................................................................... 34 
 
  
 LIST OF ABBREVIATIONS 
DNA Deoxyribonucleic acid 
A Adenine 
T Thymine 
G Guanine 
C Cytosine 
18HB 18  helix bundle 
AFM Atomic force microscopy 
DBCO Dibenzocyclooctyne 
NHS N-Hydroxysuccinimide 
EDC 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
DOX Doxorubicin 
SPR Surface plasmon resonance 
Da Dalton 
Eph erythropoietin-producing human hepatocellular receptors 
Ephrin Eph family receptor interacting proteins 
FACS Fluorescence-activated cell sorting 
nm nanometer 
FPLC Fast protein liquid chromatography 
TEM Transmission electron microscopy 
JR DNA origami rectangular hollow brick 
s.e.m. Standard error 
  
  
 
1 
1 INTRODUCTION 
1.1 THE DNA ORIGAMI METHOD 
Deoxyribonucleic acid (DNA) is the biomolecule that stores genetic information 
essential to maintain and reproduce life.  Using its four unique bases, Adenine (A), Thymine 
(T), Cytosine (C) and Guanine (G) as building blocks, it possible to generate virtually 
unlimited combinations of DNA sequences, hence a massive amount of biological 
information can be stored within. According to the complementary base pairing rule, A can 
form two stable hydrogen bonds with T, and C can form three stable hydrogen bonds with G 
(Figure 1a). Two DNA strands that are complementary to each other can interact and form a 
DNA double helix. However, the versatility and programmability of DNA is not limited to 
vast genetic information storage, it can also be engineered and applied to non-genetic 
applications. 
In the 1980s, Prof. Nadrian Seeman demonstrated that by using a combination of 
partially complement linear and circular oligonucleotides, it is possible to fabricate a 
nanoscale cube with DNA
1
 (Figure 1b). This experiment established the field of DNA 
nanotechnology. In 2006, Paul Rothemund revolutionized the field of DNA nanotechnology 
by introducing the “scaffolded” DNA origami method
2
.  He showed that by using a long 
ssDNA “scaffold” and hundreds of short synthetic “staple” oligonucleotides that are designed 
to hybridize to different sections on the scaffold, it is possible to “fold” the long ssDNA 
scaffold into virtually any nanoscale object with high yield (Figure 1c).  
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Figure 1. a. DNA double helixes are consisting of two complementary DNA chains. Adenine forms two 
hydrogen bonds with Thymine, Guanine forms three hydrogen bonds with Cytosine. b. The DNA nanocube 
synthesized by Professor Nadrian Seeman
1
. c. The DNA origami method developed by Paul Rothemund
2
 (top 
right panel: computer rendering of the DNA nanostructures, bottom right panel: AFM micrographs of the DNA 
nanostructures, the boxes are 165 nm x 165 nm). b and the right panel of c was adapted with permission from 
nature publishing group. 
The groundbreaking work of Nadrian Seeman and Paul Rothmund has ushered 
scientists into a new era of nanotechnology. With DNA nanotechnology and DNA origami, it 
is possible to designed and fabricate nano-scale objects from the bottom up with high fidelity. 
Using these promising tools to manipulate matter at the nanoscale, successful applications of 
DNA origami can be seen in the fields of chemistry
3
, structural
4
 and cell biology
5–7
, drug 
delivery
8,9
 and physics
10
.  
In this thesis, we applied the DNA origami method to fabricate well-defined patterns of 
various biomolecules, and explored the fascinating interplay between the patterns, cellular 
behavior and immunological interactions.  
1.2  BIOORTHOGONAL CLICK CHEMISTRY AND BIOCONJUGATION 
One of the main challenges in the application of DNA origami is to decorate the 
origami nanostructures with various functional groups, such as proteins, chemicals and 
nanoparticles. Most common methods include: 1) incorporation of oligonucleotides that are 
directly modified with the functional group of interest (Figure 2, top panel). 2) incorporation 
of oligonucleotides modified with chemical linkers that can be further conjugated to the target 
functional group via click chemistry and 3) tagging of target functional group with a short 
handle oligonucleotide that can be further hybridized to a DNA origami that express the 
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complement oligo (Figure 2, bottom panel). All of these approaches require rapid and robust 
chemical reactions that are compatible with biological conditions to crosslink DNA with 
desired functional groups. 
 
Figure 2. Different approaches to functionalize DNA origami nanostructures. Top panel: functional groups (blue 
circles) that are thermo-stable were directly incorporated in the folding process (color lines: staple 
oligonucleotides); Bottom panel: Heat sensitive functional groups such as the majority of proteins were 
conjugated first to a complementary handle oligonucleotide and then hybridized to folded nanostructures. 
Click chemistry is a specific set of chemical reactions that are fast, specific and can be 
carried out in biological buffers. Since its first description in 2001 by Prof. Sharpless
11
, click 
chemistry has become one of the most important methods to tag biomolecules in a wide range 
of applications
12
.  Some examples
11
 of click chemistry include: hydrazone click chemistry, 
[3+2] cycloadditions, Diels-Alder reactions and [4+1] cycloadditions.  
In this thesis, we applied NHS/EDC coupling, hydrazone chemistry and [3+2] 
cycloadditions to functionalize our DNA nanostructures (Figure 3). If we aim to functionalize 
our DNA origami nanostructures with proteins, we first modify both the protein of interest 
and the handle oligonucleotide with two different bifunctional linkers, and then cross link the 
two modified molecules with click chemistry (Figure 3 b and c). In the case of small 
molecule functionalization (such as haptens or fluorophores), we react amine modified oligos 
with the small molecules that are activated with NHS (Figure 3a), and incorporate the 
modified oligonucleotide in the folding process (Figure 2). We developed and adapted 
several protocols that are tailored to each type of functionalization we wish to achieve: 
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Figure 3. Different approaches in bio-conjugation. Blue line: amine modified oligonucleotide; DBCO: 
dibenzocyclooctyne; Functional Group: The functional molecule to be introduced to DNA origami.  
1) NHS/EDC coupling (Figure 3a): 
Small molecules that contain an NHS activated carboxylic acid can be reacted with amine 
modified oligonucleotides or accessible lysine residues on proteins. This is perhaps the most 
widely used method to tag biomolecules, and it is the first step in our preparation of our 
conjugates, but it suffers from several drawbacks: a) NHS activated carboxylic acids can be 
degraded by water, so in these type of reactions there is always a competition between amide 
bond formation and degredation, hence an excess of these NHS activated chemicals is often 
required. b) When tagging proteins, this technique targets any accessible lysine on the 
protein, so there is a risk to denature the protein if the tagging occurs at the binding or active 
site. Because of these reasons, care must be taken so we only obtain the minimum amount of 
tagging necessary to proceed with further conjugations.  
2) Hydrazone click chemistry
11
 (Figure 3b): 
A hydrazine and an aldehyde can condense and form a hydrazone bond in mildly acedic 
conditions (pH6.0). By tagging proteins with hydrazine, and olignucleotides with 
benzaldehyde, we can crosslink the two molecules. One of the advantages of this technique is 
the hydrazone bond produced has a unique absorbace of light at 350 nm and a known 
extinction coefficient, which makes the characterization of the conjugation yield easier. We 
can use the bradford assay to measure the protein concentration, and the absorbance at 350 
nm to estimate the hydrazone concentration, hence the conjugation yield can be quantified 
(ratio between the protein and the oligonucleotide). 
3) Copper-free Alkyne-Azide [3+2] cycloaddition
13
 (Figure 3c): 
This reaction is modified from the well-known Huisgen 1,3-Dipolar Cycloaddition, which 
uses a copper catalysis to catalize the cycloaddition between an alkyne and an azide, 
producing a triazole compound. The presence of copper can denature proteins and residues of 
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the metal can be cytotoxic.  This drawback can be eliminated by using strained cyclic alkynes 
(such as cyclic-octyne). The alkyne group becomes much more reactive towards the azide 
due to its ring strain, and the cycloaddition can be carried in physiological conditions without 
the presence of copper.  
4) Site specific tagging of the histidine tag with the bis-sulfone functional group
14
 (Figure     
3d): 
To achieve site specific tagging of proteins, we adapted and develped this technique to “tag” 
and functionalize the histidine tag of proteins with cyclic-octyne, which can be further 
conjugated to an azide modified handle oligonucleotide.  Lowering the pH of the reaction 
buffer to around 6.3, we will protonate the vast majority of accessible lylsine residues on 
target protein, making them less nucleophillic, while the nucleophilic imidazole nitrogen on 
histidine remains unprotonated and nucleophilic. The bis-sulfone group then reacts with two 
histidines via two subseqent micheal additions, forming a heterocyclic 19 member ring, 
tagging the histidine tag site specifically with DBCO.  
1.3 EPHRIN AND EPH 
Membrane bound receptor-ligand interactions and their downstream signaling events 
regulate to a large extent the communication between cells
15
. In particular, the Eph receptors 
(erythropoietin-producing human hepatocellular receptors) are the largest known subfamily 
of receptor tyrosine kinases, and are activated upon binding with their membrane bound 
ephrin ligands. Eph-ephrin interactions were described to play critical roles in embryonic 
development, axon guidance and cell migration, and are often disrupted in various forms of 
cancer
16
. Considering the critical role of abnormal Eph-ephrin interactions in cancer, it is 
essential to understand their subtle signaling mechanisms in order to develop targeted 
therapeutics.  
Studies have shown that Eph-ephrin interaction initiates further downstream signaling 
predominately via the formation of higher order receptor-ligand clusters that form at the 
cellular membrane
17,18
 (Figure 4), and remains inactivated when the formation of such 
clusters is impeded
19
. The course of Eph receptor signaling has been classified into several 
steps: initiation of the signaling process by a single ephrin ligand-Eph receptor binding event 
or “seeding”; the seeding step is followed by hetero-tetramerization of two ephrin-Eph 
complexes and further recruitment of these complexes into higher order signaling clusters. 
This is supported by crystallography data
17
, which demonstrate that specific receptor-
receptor, receptor-ligand interaction modes ensue the formation of receptor-ligand 
heterodimers, tetramers and oligomers.  
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Figure 4. The proposed mechanism of ephrin/Eph clustering and signal transduction. 
Membrane protein clustering events were hypothesized to function at the nanometer 
scale
20
. To probe the nanoscale mechanisms of Eph-ephrin interaction, we have chosen the 
DNA origami method
2
 and developed a technique to present ephrin-A5-Fc ligands (a hybrid 
of ephrin-A5 and Fc that spontaneously forms dimers) at well-defined distances. Due to the 
ability of our DNA nanostructure to arrange ephrin-A5-Fc with high precision, we coin the 
term “ephrin-A5-Fc nanocalipers”. Using these ephrin-A5-Fc nanocalipers, we demonstrated 
that it is possible to induce ephrin-A5 distance-dependent EphA2 receptor activation and 
cellular behavior in a breast cancer cell line. 
1.4 THE FLEXIBILITY AND BINDING PATTERNS OF ANTIBODIES 
Antibodies are one of the key components in the mammalian immune system; they 
were evolved to recognize and bind to antigens that are present on foreign organelles, and 
either physically block the protein-protein interactions required for the organelle’s survival 
and function, or act as a tag to initiate an attack from other components in the immune 
system. There are five classes of antibodies in the mammalian immune system, IgA, IgD, 
IgE, IgG and IgM, IgG performs the majority of antibody based immunity.  IgG are large Y 
shaped proteins, with two antigen binding arms (Fab) and one stem region (Fc) that 
communicates with other components in the immune system. The two arms are joined 
together with the stem via a flexible hinge region to introduce flexibility to the molecule.  
The flexibility of the antibody hinge region allows the two antigen binding arms to bind 
to wider ranges of antigen distances and orientations, which can translate into different 
immune responses
21
. Early studies showed that antibodies can form linear dimers, triangular 
timers, and rectangular tetramers when multiple antibodies are crosslinked with dimers of 
small molecule antigens
22
. Recent transmission electron tomography studies revealed that the 
dynamic distance between the two Fab arms in human IgG1 is between 6 and 12 
nanometers
23
. However, these studies are either based on imaging of fixed antibodies, or non-
antigen bound antibodies, so precious kinetic and dynamic behaviors of the antibody-antigen 
interactions, with respect to the molecule’s flexibility are lost.  
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The assembly of antibody clusters subsequent to antigen binding on target organelle plays a 
critical role in the initiation of immune responses
24
. However, dynamics of detailed clustering 
interactions between multiple antigen and antibodies has not been described.  
 
Figure 5. An overview of the patterned surface plasmon resonance (PSPR) method. a. In contrast to conventional 
SPR where the ligand of interest is randomly coupled to the surface, the PSPR method offers precise 
manipulation of ligand patterns on the surface. b. DNA origami antigen patterns were created by using different 
combinations of antigen modified staples. c. The antigen nanopinboards were immobilized on the SPR surface 
via oligonucleotide hybridization. An increasing concentration of antibodies was flown over the surface and 
binding interactions were recorded (scale bar for the TEM micrograph of the antigen nanopinboard: 50 nm, blue 
dots: antigens).   
Surface plasmon resonance
25
 is a technique that utilizes the changes in the absorbance 
of total internal reflected light when mass (such as proteins) are deposited on a gold surface. 
One of the binding partners, such as a receptor, is commonly immobilized on the gold surface 
via NHS/EDC coupling, and a concentration series of the ligand is flown through the surface. 
Once the ligands bind to the receptor, the mass on the surface increases, resulting in an 
increase in the SPR signal (resonance units), and recording the changes in SPR signal over 
time will result in a binding curve (a typical single cycle kinetics binding curve is shown in 
Figure 5c, top right panel). The binding curve is then fitted with a 1:1 Langmuir binding 
model to obtain the binding rates and constants. 
Using DNA origami, we developed the patterned surface plasmon resonance (PSPR, 
Figure 5) technique, where we fabricate DNA nanopinboards to present antigens at different 
distances and patterns on an SPR surface (Figure 5c), and applied this method to study the 
interplay between the structures of the hinge region in different antibody subclasses and its 
binding kinetics to antigen dimers arranged at various distances. We also applied this 
technique to study the clustering interactions between multiple antibodies and antigens. 
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1.5 PRODUCTION AND PURIFICATION OF FUNCTIONALIZED DNA ORIGAMI 
The DNA origami method has enabled the arrangement of matter and function at the 
nanoscale with high precision
26
. Oligonucleotides that control the folding of DNA origami 
structures can be modified with functional groups, and incorporated into the structures with 
high programmability. However, the realization of the functionalization process of these 
nanostructures can be tricky, in particular, the purification step that removes excess 
production materials from the functionalized DNA nanostructures. The functional groups are 
normally added in excess to the nanostructures to ensure good incorporation yield, but the 
presence of excess functionalization material can interfere and introduce errors in 
downstream applications. Hence robust methods to remove these excess materials are critical 
to obtain reliable experimental results.  An additional complication arises when the functional 
groups, such as fluorophores and proteins, display unspecific interactions with membranes, 
resins and plastics
27
. These properties tend to render the functionalized structures stickier and 
an improper choice of purification method can result in poor recovery yield or poor purity.  
 
Figure 6. An overview of DNA origami functionalization and purification
28
. a and b. functional groups 
conjugated to the handle oligonucleotide were hybridized to the structures. c. excess functional groups were 
removed via the seven methods tested in this study. d. purified functionalized DNA origami were obtained.   
A variety of methods exist for the purification of DNA or protein
29
, but these methods 
involve denaturing or breaking up the biomolecules other than the desired product. The 
purification of protein-decorated origami nanostructures requires the process to retain both 
the biological activity of the proteins, and the structural integrity of the nanostructures. Also, 
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most size-exclusion based methods are optimized to purify molecules in the kDa range, not 
supramolecular structures in the order of MDa. Because of these reasons, new and adapted 
methods have been developed to purify functionalized DNA origami structures, these 
methods include: poly-ethylene glycol fractionation
30,31
, gel extraction
32
, glycerol gradient 
ultracentrifugation
33
, size exclusion columns
34
 and ultrafiltration
5
 (Figure 6). But there is a 
lack of studies comparing the efficacy of these methods in a similar setup.  
To compare the methods in a similar setup, we selected three functionalized DNA 
origami as model systems: Alexa488 modified DNA 18 helix bundle (A488-18HB), IgG 
modified DNA 18 helix bundle (IgG-18HB) and ferritin modified 18 helix bundle (ferritin-
18HB). A488 represent purification of small molecules, IgG represents purification of 
moderate size (around 150 kDa) proteins and ferritin represents purification of large (around 
500 kDa) proteins (Figure 6). We also demonstrated the efficacy of two adapted purification 
methods that have not been previously applied to purify DNA origami: Magnetic bead 
capture and size exclusion fast protein liquid chromatography.  
1.6 DNA ORIGAMI AS DRUG DELIVERY VESSELS 
DNA origami nanostructures are highly programmable and can be easily functionalized 
with a plethora of functional groups
5,6
, these properties make the nanostructures a potential 
vessel to deliver and release drugs with high specificity. DNA origami has been successfully 
applied to targeted delivery of oligonucleotide aptamers
7
 and therapeutic antibodies
35
. 
Doxorubicin belongs to the class of anthracyclines that intercalate DNA and inhibit 
translation and transcription, and it is commonly used in cancer therapy. A previous study 
demonstrated that by engineering the global twist of dsDNA in DNA origami structures
36
, it 
is possible to tune the DNA intercalation process and capacity of Doxorubicin. In this thesis, 
we further applied this phenomenon to construct a DNA drug delivery vessel with controlled 
release properties. 
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2 MATERIALS AND METHODS 
2.1 DESIGN AND FABRICATION OF DNA ORIGAMI NANOSTRUCTURES 
2.1.1 caDNAno 
caDNAno
37
 is a software developed to ease the process of 2D and 3D DNA origami 
nanostructure design (Figure 7). dsDNA helices are arranged in a honeycomb fashion and 
adjacent helices are cross-linked together via immobile holiday junctions to construct desired 
DNA origami nanostructures. After completing the design of our nanostructure, we can select 
the most optimal scaffold and export a list of oligonucleotides required for the assembly of 
the nanostructure.  
 
Figure 7. A snapshot of the caDNAno software and a maya 3D rendering of the 18HB.  
In this thesis we used caDNAno to design an 18 helix bundle (18HB), a twisted 18 helix 
bundle, and a rectangular hollow brick and applied these DNA nanostructures to study cell 
signaling, antibody binding and drug delivery.  
2.1.2 Fabrication the DNA origami nanostructures 
Engineered M13 phage genomic ssDNA was used as the scaffold (p7560 and p8634) 
for our DNA nanostructures, and they were prepared as described below: 
A single colony of Escherichia coli JM109 was picked and transferred to 25 ml LB and 
cultured overnight at 37
o
C in a shaking incubator. 3 ml of the overnight culture was diluted 
into 250 ml 2xYT, and cultured in the same shaking incubator. The phages (p7560 or p8634) 
were added to the bacteria culture when its optical density reaches 0.5 at a multiplicity of 
infection (MOI) of 1, and the whole culture was incubated for an additional 5 hr. The culture 
was transferred into a 250 ml centrifuge bottle and centrifuged twice at 4000 rcf for 25 mins 
4
o
C, transferring into a fresh centrifuge bottle in between. 10g PEG 8000 and 7.5g NaCl was 
added to the supernatant, and was incubated in an ice water bath for 30min. The supernatant 
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was then centrifuged at 10000 rcf for 30 mins 4
o
C, in this step the phages were pelleted. The 
phage pellet was then re-suspended in 10 ml Tris buffer (pH 8.5), added 10 ml of 0.2 M 
NaOH with 1% SDS, mixed gently by inversion and incubated for 3 min at room 
temperature. Afterwards, 7.5 ml of 3 M KOAc (pH 5.5) was added and the mixture was 
mixed gently by swirling, and incubated on ice for 10 min. The mixture was centrifuged at 
16500 rcf for 30 min 4
o
C, and the supernatant, which contains the M13 ssDNA, was added 
50 ml of 99.5% EtOH, mixed gently and incubated in an ice water bath for 30min before 
centrifuging at 16500 rcf for 30 min 4
o
C. The DNA pellet was washed with 75% EtOH, and 
centrifuged again at 16500 rcf for 10 min 4
o
C. The pellet was dried at room temperature for a 
minimum of 15 min, and re-suspended in 10 mM Tris (pH 8.5). The concentration of the 
ssDNA was measured with NanoDrop, and the quality and purity was characterized by 
agarose gel electrophoresis (1.5 % w/v agarose gel with 0.5 mg/ml ethidium bromide in 0.5x 
TBE as running buffer). 
The staple oligonucleotides were ordered from bioneer, eurofins or integrated DNA 
technology. The staples were grouped into different subclasses (The core, protruding and 
anchoring staples) and pooled together to a final concentration of 400 nM for each 
oligonucleotide.  
The nanostructures were folded in the following conditions: 20 nM M13 ssDNA 
scaffold, 100 nM for each staple (5 times excess to the scaffold), various MgCl2 
concentrations (13 mM for the 18helix bundle and 6 mM for the hollow brick), 5 mM Tris 
(pH 8.5) and 1 mM EDTA. The mixture was placed in a thermocycler, heated up to 80 
o
C for 
heat denaturation followed by a slow cooling process from 80 
o
C to 60 
o
C over 20 mins, and 
60 
o
C to 24 
o
C for 14 hr. The folded structures were separated from excess oligonucleotides 
via Amicon ultrafiltration (described below). The quality of the folded and purified structures 
were accessed by running them on a 2% w/v agarose gel pre-stained with EtBr.   
2.1.3 Bioconjugation between proteins and oligonucleotide handles 
Ephrin-A5-Fc and human IgG were purchased from R&D systems; horse spleen 
ferritin was purchased from Sigma-Aldrich. Amine modified oligonucleotides were ordered 
from either bioneer or integrated DNA technologies.  Several different approaches were 
selected to perform the bioconjugation of our protein of interest to a handle oligonucleotide 
that allows further hybridization to the DNA nanostructures: Hydrazone click chemistry and 
two variants of copper free alkyne azide click chemistry that target either accessible lysine 
residues or His-tags.   
Hydrazone click chemistry:  
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This method is separated into two sections: 1) 4FB (succinimidyl-4-formylbenzamide) 
modification of anime modified oligonucleotides and 2) S-HyNic (succinimidyl-6-hydrazino-
nicotinamide) modification of target protein and conjugation to the 4FB modified 
oligonucleotide.  
1) 4FB modification of anime modified oligonucleotides: 
The 3 prime amine modified oligonucleotide was re-constituted to a concentration of 0.2 mM 
in , washed with the same buffer three times in a vivaspin 5k MWCO spin column (15000 
rcf, 12 min room temperature) to remove unwanted residual chemicals, and concentrated to 2 
mM.  Sulfo-S-4FB was dissolved in anhydrous DMF (0.172M), and 12.5 uL was added to the 
concentrated oligonucleotide, and the mixture was incubated at room temperature for 1hr. An 
additional portion (12.5 ul) of Sulfo-S-4FB in DMF was added, and the mixture was 
incubated at room temperature for another hour. The modified oligonucleotides purified with 
ultrafiltration 8 times(Vivaspin 5k MWCO, 15000 rcf 12min room temperature, buffer: PBS 
pH 6.0), and concentrated to roughly 2 mM. 
2) Sulfo-S-HyNic modification of target protein and conjugation to the 4FB modified 
oligonucleotide: 
100 ug of lyophilized target protein was reconstituted in 100ul PBS pH 7.4 and washed with 
zeba spin desalting columns (7k MWCO) equilibrated with the same buffer. Sulfo-S-Hynic 
was dissolved in anhydrous DMF (7.3 uM). 2 ul Sulfo-S-Hynic was added to the protein 
solution, and incubated with occational pipetting for 2 hr. The modified protein was buffer 
exchanged into PBS pH 6.0 with zeba spin desalting columns, and 10 ul of the 4FB modified 
oligonucleotide was added. The mixture was incubated at room temperature for 2 hr with 
occational pipetting. Finally the oligonucleotide conjugated protein was purified with 
ultrafiltration (Amicon ultra 0.5, 50k MWCO, 10000 rcf 1 to 3 min per spin and a total of 8 
spins). The protein concentration was quantified with the bradfor assay, and conjugation 
efficiency (the concentration of the hydrazone bond) was quantified with UV-VIS, in 
particular the absorbance at 350 nm.  
Copper free alkyne azide click chemistry: 
1) Targeting lysine residues on the protein: 
100 ug of target protein was reconstituted in 200 ul PBS (pH 7.4) and buffer exchanged to 
100 mM NaCO3 buffer (pH8.3) with zeba spin desalting columns (5k MWCO). 
Dibenzocyclooctyne-N-hydroxysuccinimidyl ester was dissolved in anhydrous DMF (5 mM), 
and was added to the target protein solution with 6 times molar excess, and the mixture was 
incubated at room temperature with occasional mixing for 4 hr. The protein mixture was 
buffer exchanged to PBS (pH7.4). The azide modified oligonucleotide was dissolved in PBS 
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(pH7.4) at a concentration of 100 uM. The azide modified oligonucleotide was added to the 
protein mixture in a 10 times molar excess and the whole mixture was incubated at room 
temperature for 4 hr with occasional mixing. After the incubation, the protein-oligonucleotide 
conjugate was purified with ultrafiltration (Amicon Ultra 0.5, 50k MWCO, 10000 rcf, 1-3 
min for each spin and a total of 8 spins). The final concentration of the conjugated protein 
was measured with the Bradford assay.  
2) Targeting His-tags on the protein: 
This protocol is carried out as in 1), but the protein was buffer exchanged to PBS (pH 6.3) 
and added 6 times molar excess of Bis-sulfone-PEG4-DBCO (10 mM in anhydrous DMF) to 
modify the protein. Conjugation to the azide modified oligonucleotide was carried out the 
same way as in 1). 
2.1.4 Functionalization of DNA origami nanostructures  
We have two approaches to functionalize our DNA origami nanostructures: 1) when 
working with heat sensitive substances such as proteins, we would conjugate the protein with 
an oligonucleotide handle and hybridize it to folded nanostructures and 2) when working with 
substances that can survive the heat denaturation process during the folding, we would 
include the functionalized oligonucleotides directly in the mixture of staples. In more detail: 
1) We designed the nanostructures to express “pairs” of protruding oligonucleotides, with the 
protruding sequence complement to the handles on conjugated proteins, each pair of 
protruding oligo is defined as one protruding “site”. We can increase the hybridization yield 
dramatically by using pairs of protruding oligos instead of using single protruding oligos, and 
at the same time we observed that only one single protein-oligo conjugate can hybridize to 
the pair of protruding oligos. The nanostructures are adjusted to a final concentration of 20 
nM and the conjugates were added  in 5 times molar excess to each protruding site and 
incubated at 37
O
C for one hour, followed by a rapid cooling to 22
o
C and incubated at the 
same temperature for 14 hr. 
2) Oligonucleotides that are modified with haptens (small molecule antigens) were 
incorporated directly in the DNA origami folding.  
2.1.5 Purification of the functionalized DNA origami nanostructures 
It is of crucial importance to fabricate our functionalized DNA origami nanostructures 
with high yield and purity, as contamination from productions materials (excess proteins) will 
introduce errors into our cell experiments or kinetics measurements. Below are the detailed 
protocols for the most reliable methods we used in this thesis:  
1) Ultrafiltration with Amicon spin columns: 
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A maximum of 200 ul 20 nM folded nanostructures was transferred into an amicon ultra 0.5 
spin column, and spun at 10000 rcf for 1-2 mins at room temperature. A total of five to six 
spins was required to remove all excess staples. 
Alternatively, when purifying protein modified nanostructures, we need to passivate the 
membrane to reduce non-specific binding and increase the recovery yield. The passivation 
was carried out by pipetting 400 ul of 5% w/v pluronics into the columns and incubated 
overnight. The passivated column was washed with water six times before introducing the 
sample. Purification of the samples were carried out as described above (2.1.3).  
2) Gel filtration with Sepharose 6B: 
11 ml of crude Sepharose 6B size exclusion resins in 20% ethanol were bufferexchanged to 
PBS (pH 7.4) by repetitive centrifugation (800rcf, 1 min) and resuspension (in 50 ml PBS) 
for a total of six times. The final concentration of the resin slurry was adjusted to 50% v/v. 
The resins were loaded into empty spin columns, one column with 800 ul slurry and another 
with 460 ul slurry. The columns were placed on collection tubes with 1ul 1M MgCl2 loaded 
at the bottom, this is to replenish the MgCl2 that will be removed during the purification 
process, since we discovered that if the resins were equilibrated in PBS containing MgCl2, the 
recovery yield decreases dramatically. The loaded columns were spun at 800 rcf for 1 min to 
remove the buffer. 100 ul of nanostructures was passed through the two columns 
sequentially, first through the column loaded with 800 ul slurry and second through the one 
loaded with 400 ul slurry.  
2.2 STUDYING BINDING KINETICS WITH SURFACE PLASMON RESONANCE 
2.2.1 Ephrin-A5-Fc and EphA2 binding kinetics 
Human EphA2 (extracellular domain) was immobilized on a CM3 chip. In detail: 
EphA2 was reconstituted at 1mg/ml, diluted 100 times into 10 mM Sodium Acetate buffer 
(pH 4.5) and injected over a NHS-EDC activated CM3 chip for 7 mins. EphrinA5-Fc and 
EphrinA5-Fc oligonucleotide conjugates were diluted to concentrations ranging from 12 to 
120 nM in PBS (pH7.4) supplemented with 10 mM MgCl2. Ephrin-A5-Fc nanocalipers were 
diluted to concentrations ranging from 6 to 24 nM. The samples were injected over the 
surface with a contact time of 15 min, and the binding curves were fitted with a 1:1 binding 
model to extract the binding affinity (KD). BIAcore 2000 was used to record the binding 
curves and BIAevaluation 3.2 software was used to process the data. 
2.2.2 Antibody binding kinetics 
Streptavidin was reconstituted to 1mg/ml, diluted 100 times in 10 mM Sodium Acetate 
Buffer (pH 4.5) and passed through an NHS/EDC activated CM3 chip with a contact time of 
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6 mins and 10 ul/min flowrate. Afterwards, 200 nM biotinylated anchor oligonucleotides 
were injected over the surface for 20 mins and a flowrate of 10 ul/min followed by a washing 
step with 50 mM NaOH for 5 min. Antigen nanopinboards expressing the complement of the 
anchor oligo was injected over the surface for 20 min at a flowrate of 2 ul/min. The 
immobilization processes were carried out at 25
o
C. 
For the antibody binding experiments, we used BIAcore t200. Antibodies of interest 
were diluted to a concentration close to the range to its KD, and a total of five increasing 
concentrations were injected sequentially with the single cycle kinetics method for 5 min 
each and a flowrate of 30 ul/min, followed by a dissociation step for 15 min. The binding 
curves were fitted with the t200 evaluation software, the on-rate, off-rate, KD and binding 
capacity were extracted. Depending on the binding affinity of antibody-antigen binding, the 
experiments were performed at either 25
o
C (for binding affinities in the nM range) or 37
o
C 
(for binding affinities in the pM range). 
2.3 CELLULAR SIGNALING EXPERIMENTS 
2.3.1 Cell culture and Eph receptor stimulation 
MDA-MB-231 cells were cultered in DMEM (Dulbecco’s modified eagle medium) 
supplemented with 10% FBS (Fetal bovine serum) and 1% penicillin & streptomycin. The 
cells were cultured on 16-well or micropatterned glass slides for the immunohistochemistry 
and PLA experiments. The cells were seeded at 60000 cells/ml and unbound cells were 
washed away after 1hr incubation.  
The cells were serum starved for one hour prior to EphA2 stimulation. EphrinA5 
modified nanostructures were added to the cell culture medium to a final concentration of 10 
nM Ephrin-A5-Fc concentration, and ephrinA5-Fc and clustered ephrinA5-Fc controls were 
added to the culture medium to reach the same ephrinA5-Fc concentration as the 
nanostructures. The stimulation lasted for 15 mins before fixing the cells with 10% formalin 
for 20 min.  
The proximity ligation assay (PLA) was carried out as follows: 
A PLA kit from Duolink was used in the section. The fixed cells were incubated with 
DUOlink II blocking solution in a humidity chamber (37
o
C). One anti-phosphotyrosine (1 to 
1200x dilution) and one anti-EphA2 antibody (1 to 1500x dilution) was diluted in Duolink II 
antibody diluent buffer, introduced to the fixed cells and incubate overnight at 37
o
C. After the 
incubation, the samples were washed with Duolink II wash buffer for three times and 10 min 
each. The PLA probes (Duolink II anti-Mouse + and Duolink II anti-Rabbit -) were 
introduced to the samples and incubated for 60 min at 37
o
C, and washed three times for 10 
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min with Duolink II wash buffer. Afterwards the DNA ligase (1:50 dilution in ligase buffer) 
was added to the samples and incubated for 30 min at 37
o
C, and washed twice in Duolink II 
wash buffer for 2 min each wash. The samples were incubated 37
o
C for 60 min after the 
addition of the DNA polymerase diluted (1 to 160x dilution) in Duolink II amplification 
buffer. Finally the samples were washed two times with the wash buffer. The cells were 
stained with phalloidin and DAPI, and mounted with Vectashield. The cells were imaged 
with Zeiss Cell Observer fluorescent microscope.  
2.3.2 Cell invasion assay  
The cell invasion assay was performed with ECM precoated cell culture inserts (8 um 
pores). The ECM layer was rehydrated by incubation in serum free medium for 2 hr at room 
temperature. The cells were collected with cell scrapers, followed by treatment with IgG, 
ephrin-A5 monomer, ephrin-A5-Fc, IgG clustered ephrin-A5-Fc, and the nanocalipers, at a 
final ephrin-A5 concentration of 20 nM for 15 min at 37oC. 40000 cells were seeded into 
each well and cultured for 24 hr and fixed with 10% formalin and permeabilized with 100% 
methanol. Non-invading cells were removed from the interior of the insert, the remaining 
cells were stained with antibodies from the supplier (Millipore) and DAPI.  The cells were 
imaged with Zeiss Axioscope 2 microscope.  
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3 RESULTS AND DISCUSSION 
We used the DNA origami method to create well-defined patterns of various 
biomolecules, and applied these patterned biomolecules to study cell signaling events and 
antibody binding. We also customized a selection of purification methods to achieve quality 
fabrication of these biomolecule-decorated DNA origami nanostructures. Finally we 
fabricated a DNA origami nanostructure with an engineered twist to deliver anticancer drugs 
in a controlled release fashion.  
3.1.1 Folding and functionalization of DNA origami nanostructures (Paper I) 
We designed a selection of DNA origami nanostructures, one rod, one twisted rod and 
one rectangular brick with caDNAno.  The rod was used to pattern antigens and ephrins; the 
twisted rod was used for drug delivery studies and the rectangular hollow brick was used to 
pattern antigens in 2D.  
The folding of DNA origami structures generally requires the presence of divalent 
cations, such as Magnesium (Mg
2+
), to neutralize the negative charge repulsion between the 
phosphodiester backbones. But excess Mg
2+
 ions can crosslink the scaffolds and form 
aggregates of DNA. Different structures exhibit different amounts of crossovers and DNA 
packing density, therefore each DNA origami structure has a Mg
2+
 concentration “sweet 
spot” where its concentration is enough to neutralize the charge repulsion between DNA back 
bones and not high enough to aggregate the scaffold. For each DNA origami nanostructure 
we performed a magnesium concentration screening to find the optimal concentration for its 
folding (Figure 8).  
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Figure 8. A standard magnesium screening experiment for DNA origami nanostructures. The 18HB was folded 
in a range of MgCl2 concentrations. At low MgCl2 concentrations (1 mM) the structures do not fold, resulting in 
a band that runs slower than the scaffold (p7560 ssDNA). As the MgCl2 concentration increases, the 18HB starts 
to fold, and between 10 and 13 mM reaches its optimal folding (fast running, intense and sharp bands). At high 
MgCl2 concentrations the folding start to aggregate (>16 mM MgCl2). A transmission electron micrograph of a 
well folded 18HB at 13 mM MgCl2 is shown in the right panel, the box is 150 nm x 35 nm. 
Functionalization of our DNA origami nanostructures were performed in two ways, 
depending on the functional group (Figure 2): 1) small chemicals that are thermo stable was 
conjugated directly to staple oligonucleotides and incorporated in the folding process. 2) 
Proteins or chemicals that are sensitive to heat are conjugated to a handle oligonucleotide and 
further hybridized to folded DNA nanostructures.  
To quantify the functionalization yield of proteins, in particular ephrin-A5-Fc, a gel 
retardation assay was applied and successful hybridization of the ephrin-A5-Fc-
oligonucleotide conjugates to the nanocalipers can be seen as retardation in the gel band 
(Figure 8a), and the retardation distance corresponds to the amount of proteins immobilized 
on the structures. We also used transmission electron microscopy (TEM) to image the ephrin-
A5-Fc nanocalipers, and observed that the ephrin-A5-Fc appear as white clouds at the 
designed positions: 0 nm (NC0, a single ephrin-A5-Fc on the tip of the nanocaliper), 42.9 nm 
(NC40) and 101.2 nm (NC100) (Figure b-e).  
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Figure 8. Characterization of ephrin-A5-Fc nanocalipers (NC empty, NC0, NC100 and NC40)
6
. a. Gel 
retardation assay (2% agarose gel pre-stained with EtBr) showing the gradual decrease in the migration speed of 
the nanocalipers as the number of immobilized ephrin increases. b-e. TEM micrographs (150 nm x 35nm) of the 
nanocalipers; the ephrins can be seen as white clouds at the designed distances (0, 42.9 and 101.2 nm).  
3.1.2 Characterization of the bio-availability of ephrin-A5-Fc nanocalipers 
(Paper I) 
It is crucial to characterize the bio-availability of the proteins immobilized on the DNA 
origami nanostructures. In the case where we produced ephrin-A5-Fc nanocalipers, we used 
surface plasmon resonance (SPR) to compare the binding constants of unconjugated ephrin-
A5-Fc, oligonucleotide conjugated ephrin-A5-Fc and ephrin-A5-Fc nanocalipers (Figure 9). 
We immobilized the EphA2 receptor on the SPR surface and flown over the ephrins and 
nanocalipers at various concentrations, which would give us a series of binding curves. After 
fitting the binding curves with a 1:1 Langmuir binding model, we obtained the binding 
constants, and the results are shown in figure 9. 
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Figure 9. Surface plasmon resonance characterization of ephrin-A5-Fc conjugates and ephrin-A5-Fc 
nanocalipers
6
. Binding curves of ephrin-A5-Fc conjugates (grey curves) and ephrin-A5-Fc nanocalipers (green, 
blue and purple curves) to immobilized extracellular domain of human EphA2. The curves were fitted with a 1:1 
Langmuir binding model and the apparent dissociation constants were obtained, and shown in the inset. 
The results show that the unmodified ephrin, conjugated ephrin and nanocalipers 
modified with one ephrin-A5-Fc (NC0) exhibits similar binding affinity towards EphA2, 
indicating that the bio-availability of these proteins were retained throughout the production 
process. Moreover, we saw an increase in the binding affinity for the two nanocalipers 
decorated with two ephrins-A5-Fc, indicating that there is an avidity effect and the bio-
availability of both ephrin-A5-Fc were retained (Figure 9).   
To further investigate whether the ephrin-A5-Fc nanocalipers can bind to EphA2 expressing 
cells, we performed fluorescence activated cell sorting (FACS) experiments (Figure 10). We 
observed that cells that were treated with IgG-clustered ephrin-A5-Fc and ephrin-A5-Fc 
nanocalipers showed similar FACS signals, indicating that the cells were bound with ephrin-
A5-Fc ligands. 
 
 
21 
 
Figure 10. FACS analysis of IgG clustered ephrin-A5-Fc and ephrin-A5-Fc nanocalipers binding to MDA-MB-
231 cells
6
. Alexa-488 conjugated anti-human IgG was used to target the Fc region on the ephrin-A5-Fc.  
3.1.3 Spatial regulation of EphA2 receptor activation (Paper I) 
We applied the proximity ligation assay
38
 (PLA) to quantify the EphA2 activation level, 
and we cultured the MDA-MB-231 cells on fibronectin micropatterns to prevent cell-cell 
contact-induced EphA2 activation.  
First we studied the activation of EphA2 with conventional IgG-clustered ephrin-A5-
Fc, ephrinA5 monomer and dimers (ephrin-A5-Fc), and only IgG-clustered ephrin-A5-Fc 
was described to activate EphA2 efficiently. We observed a gradual increase in the EphA2 
activation level in the cells stimulated with the monomer, dimer and cluster, which is in line 
with previous studies, and indicating that the PLA assay is valid (Figure 11a and b).    
Next we studied EphA2 activation with ephrin-A5-Fc nanocalipers. We engineered the 
nanostructures to present either one ephrin-A5-Fc (NC0) or two ephrin-A5-Fc at 42.9 nm 
(NC40) and 100.3 nm (NC100). Cells stimulated with NC0 and NC100 showed similar 
EphA2 activation level, indicating that the two ephrin-A5-Fc failed to pose a collaborative 
effect on its activation. Cells treated with NC40 however, showed an increase in the EphA2 
activation level compared to that of NC0 and NC100, indicating that two ephrin-A5-Fc 
placed at 40 nm can elicit a proximity effect in the activation of the receptor (Figure 11c and 
d).  
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Figure 11. Proximity ligation assay to quantify EphA2 activation in MDA-MB-231 cell line
6
. a and c. each 
magenta dot represents activated EphA2; actin is presented in cyan and the nuclei in blue. scale bar: 10 um. b 
and d. quantification of magenta dots per cell and normalized to cells treated with either IgG or NC empty 
control. A minimum of N=5 was performed for each data point. Error bars are s.e.m. 
Activation of the EphA2 receptor in cancer cells with recombinant ligands was shown 
to decrease cell invasion properties
39
. We further characterized downstream events of the 
EphA2 receptor activation and study the change in the treated cell line’s invasive properties. 
We observed a similar trend as the EphA2 activation in the decrease in cell invasion of the 
ephrin-A5-Fc nanocaliper treated cells: NC40, which is more potent in activating EphA2 
resulted in a stronger decrease in cell invasion, while NC100 that is less potent in activating 
EphA2 resulted in a weaker decrease in cell invasion (Figure 12). 
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Figure 12. Eprhin-A5 nanocalipers direct the invasive properties of MDA-MB-231 cells
6
. The relative fold 
decrease in matrix invasion of cells treated with NC empty, NC100 and NC40 was quantified. * P value < 0.05, 
** P value < 0.01, *** P value <0.001. 
3.1.4 Studying antibody flexibility and complex antigen binding with PSPR 
(Paper II) 
We explored the flexibility of various antibodies by arranging two small molecule 
antigens at distances ranging from 2 nm to 28 nm with the patterned surface plasmon 
resonance (PSPR) method. We monitored the ability of the antibodies to cross-link the two 
antigens (Figure 13 top panel), which would result in a bivalent binding and a significantly 
increased apparent binding affinity. We first studied the flexibility of commercially available 
anti-digoxygenin antibodies due to its high affinity and specificity, and we observed a U-
shaped behavior when its binding affinity was plotted against antigen distances. Bivalent 
bindings between two antigens and an antibody were observed to exhibit weakened binding 
affinities when the two antigens were placed at close (2-3 nm) or far (15-17 nm) distances. 
We hypothesize that physical stress is posed on the antibody’s hinge region when the two Fab 
arms try to come close to bind to close distances, or try to stretch to bind to farther distances, 
both deviating from the two arm’s natural distance distribution. As a result, this stress will 
translate to a strained antibody conformation and decreased binding affinity. We also studied 
the binding behavior of antibodies with lower binding affinities (Figure 13 bottom panel) and 
observed that these antibodies failed to crosslink at the short and long distances, indicating 
that the binding energy is insufficient to introduce stress in the hinge region to allow the two 
Fab arms to cross-link the close and far antigens.  
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Figure 13. Applying PSPR to study the flexibility of various antibodies. x-axis: distance between two antigens 
on the same nanopinboard (0 nm distance is an antigen monomer); y-axis: fold change in the apparent 
dissociation constant (Kd app) with the strongest bivalent binding set to a value of 1.  Grey dots represent 
monovalent binding, purple dots represent bivalent binding.  
We applied the PSPR method to present antigens at various amounts and patterns, and 
study the complex interactions between multiple antibodies and antigens (Figure 14). First we 
performed a series of control experiments, to demonstrate the programmability and reliability 
of the PSPR method to arrange antigens: antigen monomers (JR1) is a monovalent binding 
control, antigen dimers are arranged either as close dimers (JR2c) to allow bivalent binding, 
or distant dimers (JR2f) to allow only monovalent binding, the antigen trimer (JR3f) control 
was arranged so that three antigens are placed further apart, also only allowing monovalent 
binding. Results show that we have satisfactory control of the antigen orientations: JR1, JR2f 
and JR3f showed monovalent binding with binding capacities of one, two and three 
antibodies respectively, and bivalent JR2 showed a strong bivalent binding with a binding 
capacity of one antibody (Figure 14).  
 
Figure 14. Applying the PSPR method to study multimeric antigen-antibody interactions. The measured apparent 
KD is plotted as blue columns; the orange secondary axis represents the binding capacity of each structure 
normalized to the monovalent control (JR1). Illustrations of the antigen patterns are presented at the bottom of 
the plot (grey square: nanopinboard, blue dots: antigen (in this case digoxygenin)), error bars are standard 
deviation, c:closely arranged antigens, f:antigens arranged at farther distances. 
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To study how antibodies interact with more complex antigen patterns with biological 
relevance, we applied the PSPR method to express antigen trimers, tetramers, pentamers and 
hexamers (Figure 14). Antigen trimer (JR3c and JR3f) and tetramers (JR4c and JR4f) were 
arranged both as closely packed clusters or separate monomers or two separate dimers. The 
antigen pentamer (JR5) and hexamer (JR6) were placed on vertices of a hexagon. The 
binding affinity of the close antigen trimer (JR3c) was between that of monovalent and 
bivalent binding, with a binding capacity of two antibodies. This indicates that the binding 
consists of a 1:1 mixture of monovalent and bivalent binding, and can be supported by our 
binding kinetics simulation.  Both the closely placed tetramer (JR4c) and the double separate 
dimer (JR4f) resulted in 2 bivalent bindings. The pentameric antigen (JR5) shows a binding 
affinity between the close trimer and a bivalent binding, and it has a binding capacity of three 
antibodies. This indicates that the binding consists of a 2:1 ratio of bivalent: monovalent 
binding. The antigen hexamer (JR6) is particularly interesting since antibody hexamers that 
self-assemble on foreign organelles were believed to play a key role in the activation of the 
complement system
24
. This requires the presence of at least six antigens in close proximity. 
However, our results show that the most dominant binding population in this scenario is three 
bivalent binding.   
3.1.5 Purification of functionalized DNA origami nanostructures (Paper III) 
To determine the purification efficiency of all seven methods tested in this study we 
used agarose gel electrophoresis (AGE) to examine the integrity and the recovery yield of the 
functionalized DNA origami structures. TEM imaging was used to complement AGE. The 
recovery yield was calculated by comparing the gel band intensity of purified functionalized 
18HB to that of unpurified functionalized 18HB. Contamination was quantified by carrying 
out the same purification protocols with samples containing only conjugates, and the 
concentration of residual conjugates (the contaminants) were measured. Three repeats were 
performed for each data point. 
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Figure 15. The two methods we adapted to purify functionalized DNA origami
28
. a. the magnetic beads capture-
release procedure (structures were folded with an extra staple that can bind to the poly T magnetic beads. After 
washing, invader oligonucleotides (the red-blue line) was added, the invader would bind first partially to the 
linker oligonucleotide (red line) and subsequently replace the linker-bound nanostructure and releasing the 
nanostructure). b. 2% agarose gel pre-stained with EtBr. Lane 1, 1kb DNA ladder; lane 2, empty 18HB; lane 3, 
non-purified IgG-18HB; lane 4, the fraction of IgG-18HB that was not captured by the beads; lane 5, purified 
IgG-18HB released from the beads. c. summary of recovery yields from the magnetic bead purification method 
n=3. d and e, TEM micrographs of magnetic bead purified IgG-18HB (d) and ferritin-18HB (e). f. a 
chromatogram of the empty 18HB purified with FPLC (superpose 6 column), the 18HB elutes at 8 ml while 
staples from the folding elutes at 17 ml. g. 2% agarose gel pre-stained with EtBr showing the content of each 
peak from f, the staple band in the lower section of the gel was contrast enhanced for visualization purposes. h 
and i, chromatograms of A488-18HB and IgG-18HB purified with FPLC, the A488 and IgG conjugates elute at 
18 ml and 15-18 ml respectively. j. summary of recovery yields from FPLC purification n=3. k. TEM 
micrograph of FPLC purified IgG-18HB. All TEM scale bars are 100 nm, error bars are standard deviations.      
Samples purified with the magnetic bead capture method resulted in recovery yields 
around 70% for A488-18HB, 57% for IgG-18HB and 30% for ferritin-18HB (Figure 15a-e). 
We suspect the relatively low recovery yield for ferritin-18HB is due to unspecific 
interactions between the beads and ferritin. We observed that IgG interacts unspecifically 
with the beads as well, but this interaction can be reduced by the addition of a nonionic 
detergent: poloxamer, which is commonly used in cell culture systems to reduce the damage 
from stirring or liquid flow. The magnetic bead capture method offers a high purification 
efficacy, which is independent of the type of contaminants as all three types of conjugates all 
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resulted in high purity. From this, we suggest that this method is a potential universal method 
for the purification of functionalized DNA origami nanostructures. 
We observe the recovery yield of FPLC experiments were sensitive to the concentration 
of divalent cations such as Mg
2+
, which could be the result of two effects combined: 1) Mg
2+
 
can bridge the negatively charged DNA phosphodiester backbone with the lone pairs of the 
hydroxyl groups on the agarose-based Superose resin. 2) DNA origami nanostructures are 
densely packed double stranded DNA, which renders the local charge density relatively high 
compared to free M13 single stranded DNA. This hypothesis can be supported by our 
experimental results: the recovery yield of the M13 single stranded DNA is significantly 
higher than that of folded 18HB. To resolve this issue we tested a selection of buffers with 
various salt concentrations, and discovered that the optimal Mg
2+
 concentration is 3 mM in 
PBS (lower Mg
2+
 concentration will denature the 18HB).  
The 18HB and all three types of conjugates were injected separately. The 18HB elutes 
at 8 ml, staples oligonucleotides from the folding elute at 17 ml, IgG conjugates elute at 15 
ml and 18 ml, A488 conjugates elute at 18 ml. There results indicate full separation of the 
conjugates from the 18HB. The recovery yield is around 50% to 60% and comparable to the 
common methods (Figure 16), while offering high sample purity (Figure 15f-k).  
The five common, previously published purification methods were first further fine-
tuned to achieve optimal purification efficacy for further equal comparison (Figure 16). 
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Figure 16. A summary of the recovery yield and contamination for all purification methods tested in this study
28
. 
All gels are 2% agarose gels pre-stained with EtBr. a. purification of A488-18HB. b. purification of IgG-18HB. 
c. purification of ferritin-18HB. Un: unpurified functionalized 18HB; UF: ultrafiltration; GE: gel extraction; GF: 
gel filtration; PEG: fractionation; MB: magnetic bead capture. Error bars are standard deviations.    
Ultrafiltration filters can be passivated with proteins or chemicals to reduce non-specific 
interactions with the sample. Bovine serum albumin (BSA) and tween are common 
passivation reagents, but they either clog the membrane (BSA) or are cytotoxic (Tween). We 
discovered that the cell culture friendly detergent poloxamer is a potent passivation reagent. 
Ultrafiltration filters passivated with poloxamer (described above), exhibit higher recovery 
yield and at the same time maintain the filter’s purification efficiency. 
Agarose gel extraction is one of the most widely used methods to purify DNA origami 
nanostructures, but its extensive hands-on time and poor recovery yield has limited its 
application to mainly TEM sample preparation.  
Gel filtration resins with the optimal cutoff can trap small molecules such as proteins 
and oligonucleotides while macromolecules like DNA origami nanostructures are eluted in 
the void volume. We discovered that divalent cations such as Mg
2+
 reduce the recovery yield 
of this method, possibly via the same mechanisms as the FPLC experiments. To resolve this 
issue we first equilibrate the resins in PBS without Mg
2+
, and introduce a 1ul droplet of 1M 
MgCl2 to the collection tube, so that the eluted DNA origami is immediately replenished with 
Mg2+ and maintain the structure’s integrity
28
.  
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PEG precipitation can result in aggregation of the purified samples, which is possibly 
due to the extensive concentration process.  
The three methods that gave the best recovery yield for Alexa488-18HB are 
ultrafiltration, magnetic bead capture and gel filtration, with 84%, 72% and 63% recovery 
yield respectively. These methods were fairly potent in the removal of excess conjugates 
(near 98% removal) (Figure 16).  
The three methods that gave the best recovery yield for IgG-18HB are: PEG 
fractionation, magnetic bead capture and gel filtration, with 72%, 57% and 53% recovery 
yield respectively. Both the magnetic bead capture and ultracentrifugation method were able 
to remove around 98% of excess IgG conjugates (Figure 16).  
The two methods that gave the best recovery for ferritin-18HB are gel filtration and 
PEG precipitation, with recovery yields around 70% and 60% respectively. All purification 
methods generally resulted in reduced efficiency in the removal of ferritin, possibly due to its 
larger hydrodynamic radius. However, the magnetic bead capture method removed more than 
99% of the ferritin conjugates (Figure 16).  
3.1.6 DNA origami drug delivery system with tunable release properties 
(Paper IV) 
We designed two 18-helix bundle nanotubes to investigate the potency of DNA 
nanostructures as drug delivery vessels. First, we designed an 18-helix bundle structure (S-
NANO) with a conventional 10.5 bases per helical turn (Figure 17a). Second we modified the 
18-helix bundle to an unnatural 12 bases per turn (T-Nano, Figure 17b), which would induce 
a stress in the structure and the structure will adapt to a global right hand twist. Intercalation 
of DOX into dsDNA would change its pitch from 10.5 to 12 bases per turn. In accordance to 
this effect, S-NANO folded in the presence of DOX resulted in deformed structures (Figure 
17c, slow-running bands in lane 3-5) while T-NANO was folded into straight, non-twisted 
structures in the presence of DOX (Figure 17d and f).  
 
30 
 
Figure 17. S-NANO and T-NANO
9
. a and b. DOX intercalation changes the twist of DNA from 21 base pairs 
per full turn to 24 base pairs per full turn. c. the folding quality of S-NANO deteriorates along with the 
increasing concentration of DOX. lane 1: 1kd DNA ladder, lane 2: p7560 ssDNA, lane 3-5: folding of S-NANO 
in the presence of DOX (16-96 uM). d. the folding quality of T-NANO increases along with the addition of 
DOX. Lane 6: p8634 ssDNA, lane 7-11: folding of T-NANO in the presence of DOX (16-96 uM) e. canDo 
simulation of T-NANO without the presence of DOX. e and f. TEM micrographs of T-NANO without (e and 
with DOX (f), the scale bars are 100 nm.  
In vitro drug release properties of S-NANO and T-NANO loaded with DOX were 
measured and compared. In addition, the M13 dsDNA was also included as an extra control. 
We observed significant differences between the drug release kinetics of S-NANO, T-NANO 
and M13 dsDNA, the T-NANO was able to retain DOX for longer periods of time compared 
to S-NANO, for example, 50% of DOX was still retained by the structures after several hours 
of incubation. Interestingly, we observe no significant difference in the drug release kinetics 
between S-NANO and dsM13 DNA (Figure 18a).  
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Figure 18. Drug release kinetics of our DNA nanostructures
9
. a. DOX, either in its free form or loaded in DNA 
was placed in a dialysis filter, and the diffusion of DOX across the membrane was measured via the fluorescence 
of DOX. The plot shows the concentration of diffused DOX plotted against time. b. the DOX loading capacity of 
S-NANO and T-NANO. x-axis: the concentration of DOX used to equilibrate the structures with; y-axis: the 
concentration of DOX bound to the DNA nanostructures measured via fluorescence, immediately after buffer 
exchanging and removal of excess DOX with ultrafiltration. 
Prior to applying T-NANO to in vitro drug delivery experiments, we characterized its 
stability in cell culture medium via a gel shift assay, and observed that T-NANO is stable in 
cell culture medium within the time span of in vitro experiments (Figure 19a).  
Current opinion suggests that DNA structures are degraded in the endosomes after being 
endocytosed
40
. We studied the capacity of DOX loaded T-NANO to kill cancer cells with a 
sulforhodamine B colorimetric assay. Three breast cancer cell lines were chosen as model 
systems: MDA-MB-231, MDA-MB-468 and MCF-7. The half-maximal inhibitory 
concentration (IC50) of DOX while delivered via T-NANO is significantly lower compared 
to that of DOX when added as its free form and DOX loaded in S-NANO (Figure 19b).  
 
Figure 19. Stability and Toxicity of T-NANO
9
. a. 2% Agarose gel electrophoresis pre-stained with EtBr (Lane 1: 
1kb DNA ladder, lane 2: p8634 ssDNA, lane 3:non-incubated T-NANO), showing the results of the incubation 
of T-NANO in the absence of DOX in cell culture medium (supplemented with 10% FBS) for 30min, 1 hr, 3 hr, 
6 hr, 12 hr, 24 hr and 48 hr (lane 4-9). b. Cytotoxicity of free DOX (blue columns) compared that of DOX 
loaded T-NANO (red columns). N=4, ** p value <0.01, *** p value <0.001, error bars: standard deviation.  
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Our results indicate that by applying a global twist to DNA origami nanostructures, it is 
possible to increase its DOX loading capacity and decrease its drug release kinetics, 
rendering these twisted nanostructures a potent candidate for drug delivery vessels. 
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